Gyros PTi Webinar

Assessing the immunogenicity of biopharmaceuticals

Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing.

By attending this webinar, you will learn:

how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies

Speakers:

Cecilia Bill, Application Scientist, Gyros Protein Technologies AB

Frida Pauly, Manager Biopharma Solutions,Euro Diagnostica AB

Cecilia and Frida will answer your questions live during the broadcast!

Date: Thursday, November 9, 2017

Time: 10:00 AM Central European Time, (4:00 AM EST, 1:00 AM PST)

6:00 PM Central European Time, 12:00 PM EST, 9:00 AM PST

Contact Benjamin at benjamin@hobsonsinstruments.com.au if you would like to participate.

Gyrolab is a trademark of Gyros Protein Technologies Group. iLite is a registered trademark of Euro Diagnostica.